Skip to content

Mobile Intervention - Physical Activity in Cancer Treatment

Mobile Intervention - Physical Activity in Cancer Treatment

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03671304
Enrollment
8
Registered
2018-09-14
Start date
2020-11-20
Completion date
2021-12-22
Last updated
2023-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma, Renal Cell

Keywords

renal call carcinoma, exercise, physical activity, mobile intervention, just-in-time adaptive intervention, affective framing, intention planning

Brief summary

Aim 1. Determine the feasibility and acceptability of the proposed mobile technology intervention to increase physical activity patients receiving treatment for renal cell carcinoma. Aim 2. Evaluate the effect of the proposed intervention components (affective framing, intention planning, and goal-setting) on changes in physical activity.

Detailed description

Recent analyses have indicated that physical activity reduces mortality risk among patients with RCC.1. Physical activity also provides additional benefits for patients undergoing treatment for cancer such as improved quality of life and sleep, and reduced treatment-related fatigue. However, individuals receiving treatment for renal cell carcinoma (RCC) often fail to engage in sufficient physical activity. Many cancer survivors experience a decrease in their physical activity after diagnosis2 and the majority of RCC survivors do not meet the recommended guidelines for physical activity.3 Traditional physical activity interventions require significant resources and present substantial barriers for participants (travel, time commitments, etc.). In contrast, mobile technologies enable delivery of interventions with significantly fewer resources. These technologies also facilitate the delivery of just-in-time adaptive interventions (JITAIs) in which intervention support is provided at only at times when an opportunity for positive changes exists.4 The purpose of this support the development of a JITAI in RCC patients. Evaluation of the acceptability and efficacy of three intervention strategies (affective framing, intention planning, goal-setting, and savoring) will determine their inclusion in the JITAI.

Interventions

DEVICEFitbit Versa

Participants will receive a Fitbit Versa and instructions on its use. Participants will be asked to wear the device for eight weeks, removing it only for charging and when engaging in activities in which the device could be submerged in water (bathing, swimming, etc.). At enrollment, participants will indicate a preferred time to receive affective framing messages and EMA prompts (morning), and intention planning prompts (evenings). Participants will receive affective framing messages and intention planning prompts on a randomized schedule, such that participants will receive each message type on 50% of days.

Sponsors

Simmons Cancer Center
CollaboratorOTHER
University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

This project will enroll 50 participants receiving treatment for RCC in an eight-week study. Using a microrandomized design, participants will receive affective framing messages and intention planning prompts on a randomized schedule, such that participants will receive each message type on 50% of days.

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

1. Ages 18 years or older 2. Diagnosed with RCC 3. \< 150 minutes of weekly moderate-to-vigorous physical activity 4. Own a smartphone (required for syncing the Fitbit device).

Exclusion criteria

1. Medical condition contraindicating exercise participation 2. Cognitively unable to give informed consent. 3. Unable to read and communicate in English

Design outcomes

Primary

MeasureTime frameDescription
Physical Activity (Daily Step Count)8 weeksPhysical Activity (daily step count) will be measured with the Fitbit.

Secondary

MeasureTime frameDescription
Fitbit Wear Compliance8 weeksAssessment of participant compliance with the intervention (days wearing the Fitbit) to determine feasibility for future trials.
Fitbit Response Compliance8 weeksAssessment of participant compliance with the intervention (response rate to intervention prompts) to determine feasibility for future trials.

Countries

United States

Participant flow

Participants by arm

ArmCount
Just-in-time Adaptive Intervention
Participants will receive a Fitbit Versa and instructions on its use. The study design is not a traditional randomized controlled trial in which participants are randomized to either the intervention or control group. Instead the study utilizes a microrandomized design. This is a within-subjects design in which participants will receive affective framing messages and intention planning prompts on a randomized schedule, such that participants will receive each message type on 50% of days. Fitbit Versa: Participants will receive a Fitbit Versa and instructions on its use. Participants will be asked to wear the device for eight weeks, removing it only for charging and when engaging in activities in which the device could be submerged in water (bathing, swimming, etc.). At enrollment, participants will indicate a preferred time to receive affective framing messages and EMA prompts (morning), and intention planning prompts (evenings). Participants will receive affective framing messages and intention planning prompts on a randomized schedule, such that participants will receive each message type on 50% of days.
8
Total8

Withdrawals & dropouts

PeriodReasonFG000
Overall Studystudy terminated7

Baseline characteristics

CharacteristicJust-in-time Adaptive Intervention
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
5 Participants
Age, Categorical
Between 18 and 65 years
3 Participants
Age, Continuous65 years
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
6 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
7 Participants
Region of Enrollment
United States
8 participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 8
other
Total, other adverse events
0 / 8
serious
Total, serious adverse events
0 / 8

Outcome results

Primary

Physical Activity (Daily Step Count)

Physical Activity (daily step count) will be measured with the Fitbit.

Time frame: 8 weeks

Population: Collected data was not considered valid to be analyzed as the application utilized with the fitbit was no longer supported and the study did not complete and was terminated.

Secondary

Fitbit Response Compliance

Assessment of participant compliance with the intervention (response rate to intervention prompts) to determine feasibility for future trials.

Time frame: 8 weeks

Population: Collected data was not considered valid to be analyzed as the application utilized with the fitbit was no longer supported and the study did not complete and was terminated.

Secondary

Fitbit Wear Compliance

Assessment of participant compliance with the intervention (days wearing the Fitbit) to determine feasibility for future trials.

Time frame: 8 weeks

Population: Collected data was not considered valid to be analyzed as the application utilized with the fitbit was no longer supported and the study did not complete and was terminated.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026